Download Your Complementary Copy of the 2025 Agenda:

Access the Agenda to Discover What 2025's Conference Will Bring:

• Hear from 22+ leading companies, including Eli Lilly, Novo Nordisk, and Boehringer Ingelheim
• Gain insights from a distinguished faculty of 22+ renowned researchers, clinicians, and industry leaders in the obesity and weight loss space
• Explore the latest advancements in obesity treatment, including novel targets and innovative combination therapies
• Understand the implications of the Lancet Commission and new regulatory guidelines and navigate the evolving regulatory landscape
• Discover cutting-edge research and innovative solutions for addressing the side effects of current drugs including muscle loss, tolerability, administration and patient continuation